• LAST PRICE
    36.7600
  • TODAY'S CHANGE (%)
    Trending Down-0.2300 (-0.6218%)
  • Bid / Lots
    36.7600/ 1
  • Ask / Lots
    36.8300/ 2
  • Open / Previous Close
    37.2550 / 36.9900
  • Day Range
    Low 36.7000
    High 37.5200
  • 52 Week Range
    Low 20.9000
    High 47.7350
  • Volume
    302,749
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 36.99
TimeVolumeIDYA
09:32 ET357437.21
09:38 ET40037.22
09:39 ET248437.51
09:43 ET160037.395
09:45 ET90037.24
09:48 ET65037.24
09:50 ET50037.05
09:52 ET30036.97
09:54 ET70037.21
09:56 ET110037.22
09:57 ET65037.22
09:59 ET130037.3
10:01 ET10037.3
10:03 ET70037.17
10:06 ET120037.14
10:08 ET230237.24
10:10 ET185037.11
10:12 ET30037.1
10:14 ET290037.1
10:15 ET62037
10:17 ET60037.07
10:19 ET704436.93
10:21 ET20036.9
10:24 ET160437.085
10:26 ET86837.08
10:28 ET210037
10:30 ET60036.87
10:32 ET143036.985
10:33 ET20036.99
10:35 ET60036.95
10:37 ET20037.03
10:39 ET160037.085
10:42 ET36037.065
10:44 ET10036.99
10:46 ET40036.95
10:48 ET20036.98
10:50 ET20036.98
10:51 ET10036.87
10:53 ET10036.87
10:55 ET10036.9
10:57 ET120037
11:00 ET20037
11:02 ET123936.97
11:04 ET10036.92
11:06 ET10036.89
11:09 ET30036.88
11:11 ET20036.9
11:13 ET99036.955
11:15 ET30036.96
11:18 ET110037.01
11:20 ET10037.09
11:22 ET30037.03
11:24 ET10037.055
11:26 ET189536.83
11:27 ET20036.81
11:29 ET30036.92
11:31 ET30036.92
11:36 ET40036.97
11:38 ET30036.95
11:40 ET33936.975
11:42 ET70036.97
11:44 ET70036.93
11:45 ET10036.86
11:47 ET30036.87
11:49 ET60036.83
11:51 ET50036.845
11:54 ET70036.87
11:56 ET20036.87
12:00 ET40036.89
12:02 ET174036.935
12:05 ET163337.02
12:07 ET2525036.96
12:09 ET488137.02
12:12 ET6473237.22
12:14 ET10037.17
12:16 ET45137.2068
12:18 ET95037.26
12:20 ET479037
12:21 ET675337
12:23 ET358037
12:25 ET602936.99
12:27 ET1062437.09
12:30 ET66037.035
12:32 ET220037
12:34 ET2169436.88
12:36 ET10036.89
12:38 ET20036.89
12:39 ET408036.92
12:43 ET50036.935
12:45 ET117536.825
12:48 ET20036.78
12:50 ET30036.78
12:52 ET40036.79
12:54 ET53036.78
12:56 ET10036.78
12:57 ET20036.78
12:59 ET110036.71
01:01 ET80036.77
01:03 ET10036.75
01:06 ET92536.76
01:08 ET160136.82
01:10 ET150036.795
01:14 ET10036.76
01:15 ET60036.76
01:17 ET10036.75
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIDYA
IDEAYA Biosciences Inc
2.8B
-18.4x
---
United StatesXENE
Xenon Pharmaceuticals Inc
2.8B
-13.8x
---
United StatesGERN
Geron Corp
2.8B
-13.2x
---
United StatesSWTX
SpringWorks Therapeutics Inc
2.7B
-7.0x
---
United StatesAGIO
Agios Pharmaceuticals Inc
2.6B
-7.2x
---
United StatesBHVN
Biohaven Ltd
3.0B
-5.1x
---
As of 2024-06-24

Company Information

IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates are darovasertib (IDE196), IDE397, IDE161 and GSK101 (Pol Theta Helicase). IDE196, a small molecule protein kinase C (PKC), inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397, is its small molecule methionine adenosyltransferase 2a (MAT2A), inhibitor. IDE161, is its small molecule poly (ADP-ribose) glycohydrolase (PARG), inhibitor. IDE196 is its clinical-stage PKC inhibitor that the Company is evaluating as a synthetic lethal combination therapy. IDE397, a MAT2A inhibitor for patients with solid tumors having MTAP deletions. IDE161 is its clinical-stage, potent and selective small molecule inhibitor of PARG for patients having tumors with defined biomarkers based on genetic mutations and/or molecular signatures.

Contact Information

Headquarters
7000 Shoreline Ct Ste 350SOUTH SAN FRANCISCO, CA, United States 94080-7604
Phone
650-443-6209
Fax
302-655-5049

Executives

Independent Chairman of the Board
Terry Rosen
President, Chief Executive Officer, Director
Yujiro Hata
Senior Vice President, Principal Accounting Officer, Head - Finance and Investor Relations
Andres Briseno
Chief Scientific Officer
Michael White
Chief Medical Officer
Darrin Beaupre

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.8B
Revenue (TTM)
$15.5M
Shares Outstanding
75.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.86
EPS
$-2.00
Book Value
$9.55
P/E Ratio
-18.4x
Price/Sales (TTM)
180.6
Price/Cash Flow (TTM)
---
Operating Margin
-1,026.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.